"HB-adMSCs for the Treatment of Patients With Multiple Sclerosis"

NCT06800404 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsing Remitting Multiple Sclerosis (RRMS)
Multiple Sclerosis

Interventions

DRUG: Autologous HB-adMSCs

Sponsor

Hope Biosciences Research Foundation